Dr. Garima Sarawgi

Allogenic Bone Marrow Transplant

A half bone marrow transplant uses a half-matched donor, usually a parent, child, or sibling. Advances in treatment have improved its success, offering a viable option for those without a full match.
A full bone marrow transplant uses a donor with identical HLA markers, usually a sibling or matched registry donor, offering the best success rates and lower risk of complications.

Autologous Bone Marrow Transplant

Autologous bone marrow transplant (BMT) is used for blood cancers like lymphoma and multiple myeloma, as well as certain solid tumors and autoimmune diseases. It carries a lower risk of immune rejection since the patient’s own stem cells are used. Allogeneic BMT is indicated for blood cancers such as leukemia (AML, ALL, CML), along with myelodysplastic syndromes, aplastic anemia, and inherited disorders like sickle cell disease. The choice between autologous and allogeneic BMT depends on the disease, patient condition, and donor availability.

CAR-T Therapy

Chimeric Antigen Receptor T-cell (CAR-T) therapy is an advanced form of immunotherapy that modifies a patient’s own T cells to recognize and attack cancer cells more effectively. It is primarily used to treat certain types of blood cancers, such as B-cell leukemia, lymphoma, and multiple myeloma. CAR-T therapy has shown remarkable success in cases where traditional treatments like chemotherapy and radiation have failed. This cutting-edge treatment offers new hope for patients with relapsed or treatment-resistant cancers.

Chemotherapy

Chemotherapy is a widely used cancer treatment that involves powerful drugs to kill or slow the growth of cancer cells. It targets rapidly dividing cells, which is a key characteristic of cancer. However, it can also affect healthy cells, leading to various side effects. Chemotherapy is often used as a standalone treatment or in combination with other therapies such as surgery, radiation, or immunotherapy, depending on the type and stage of cancer.

Factor Replacement

Factor replacement therapy is a medical treatment used to replace missing or deficient clotting factors in individuals with bleeding disorders, such as hemophilia and von Willebrand disease. These clotting factors are essential proteins that help blood clot properly to prevent excessive bleeding. People with these conditions either lack specific clotting factors or have dysfunctional ones, leading to prolonged bleeding after injuries or spontaneous bleeding into joints and organs.

Immunotherapy

Immunotherapy is a cutting-edge cancer treatment that harnesses the body’s immune system to fight cancer cells. Unlike chemotherapy, which directly attacks cancer cells, immunotherapy strengthens or modifies the immune system to recognize and destroy cancer more effectively. This treatment is particularly effective against certain types of cancers, including melanoma, lung cancer, and some types of leukemia and lymphoma. Immunotherapy can be used alone or in combination with other treatments like chemotherapy, radiation, or surgery.

Leukapheresis

Leukapheresis is a specialized medical procedure used to remove excess white blood cells (leukocytes) from the bloodstream. This treatment is primarily used for patients with conditions such as leukemia, where abnormally high levels of white blood cells can cause complications. It is also used to collect white blood cells for research, immunotherapy, or stem cell transplants.

Plasmapheresis

Plasmapheresis is a medical procedure that involves removing, treating, and returning plasma—the liquid part of the blood—to the body. This treatment is used for various conditions, including autoimmune diseases, neurological disorders, and certain blood-related conditions. It helps remove harmful substances such as autoantibodies, toxins, or abnormal proteins from the bloodstream, improving symptoms and preventing disease progression.

Targeted Therapy

Targeted therapy is a specialized cancer treatment that focuses on specific molecules involved in cancer cell growth and survival. Unlike chemotherapy, which affects both cancerous and healthy rapidly dividing cells, targeted therapy is designed to block cancer growth while minimizing damage to normal cells. This approach is used for various cancers, including breast cancer, lung cancer, and certain types of leukemia, and is often combined with other treatments such as chemotherapy, radiation, or immunotherapy.

Dr. Garima Sarawgi

A triple gold medalist and the first woman MCh Surgical Oncologist from Eastern India, Dr. Garima Sarawgi brings over 14 years of experience in advanced cancer surgeries, breast oncoplasty, women’s oncology, and preventive oncology leadership. She is a pioneer of compassionate cancer care, preventive oncology campaigns, and robotic innovations in surgical oncology in Odisha and Eastern India. Dr. Garima is a highly regarded academic speaker, researcher, social advocate, and health leader, passionately working to bridge clinical excellence with public healthcare awareness.

Contact Today Contact Today

Towards a Healthier Tomorrow

Dr. Garima Sarawgi

Best Oncologist in Bhubaneswar

Treatments

Allogenic Bone Marrow Transplant

Autologous Bone Marrow Transplant

CAR-T Therapy

Chemotherapy

Factor Replacement

Immunotherapy

Leukapheresis

Plasmapheresis

Targeted Therapy

Early Detection Saves Lives — Schedule Your Oncologist Check-Up Today

Book An Appointment with Dr. Garima Sarawgi Today.